Prospective study of serologic tests for Lyme disease

Clinical Infectious Diseases

Volumn 47, Issue 2, 2008, Pages 188-195

  Steere, Allen C ^a   McHugh, Gail ^a   Damle, Nitin ^a   Sikand, Vijay K ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; BACTERIAL DNA; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M; IMMUNOGLOBULIN M ANTIBODY;

ANTIBODY RESPONSE; ARTICLE; BACTERIUM CULTURE; BORRELIA BURGDORFERI; ENDEMIC DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHEMA CHRONICUM MIGRANS; HUMAN; IMMUNE RESPONSE; LYME DISEASE; MAJOR CLINICAL STUDY; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEROCONVERSION; SERODIAGNOSIS; SEROLOGY; SKIN BIOPSY; SKIN INFECTION; WESTERN BLOTTING;

ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; ARTHRITIS; BACTERIAL PROTEINS; BLOTTING, WESTERN; BORRELIA BURGDORFERI; CONVALESCENCE; DISEASE PROGRESSION; ENZYME-LINKED IMMUNOSORBENT ASSAY; ERYTHEMA CHRONICUM MIGRANS; HEART DISEASES; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LIPOPROTEINS; LYME DISEASE; LYME NEUROBORRELIOSIS; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SEROLOGIC TESTS; SONICATION;

EID: 46349099403     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/589242     Document Type: Article

References (31)

1. Steere AC. Lyme disease. N Engl J Med 2001; 345:115-25.
2. Recommendations for test performance and interpretation from the Second International Conference on Serologic Diagnosis of Lyme Disease. MMWR Morb Mortal Wkly Rep 1995; 44:590-1.
3. Liang FT, Steere AC, Marques AR, Johnson BJ, Miller JN, Philipp MT. Sensitive and specific serodiagnosis of Lyme disease by enzyme-linked immunosorbent assay with a peptide based on an immunodominant conserved region of Borrelia burgdorferi VlsE. J Clin Microbiol 1999; 37:3990-6.
4. Bacon RM, Biggerstaff BJ, Schriefer ME, et al. Serodiagnosis of Lyme disease by kinetic enzyme-linked immunosorbent assay using recombinant VlsE1 or peptide antigens of Borrelia burgdorferi compared with 2-tiered testing using whole-cell lysates. J Infect Dis 2003; 187:1187-99.
5. Case definitions for public health surveillance. MMWR Morb Mortal Wkly Rep 1990; 39(RR-13):1-43.
6. Vaz A, Glickstein L, Field JA, et al. Cellular and humoral immune responses to Borrelia burgdorferi antigens in patients with culture-positive early Lyme disease. Infect Immun 2001; 69:7437-44.
7. Steere AC, McHugh G, Suarez C, Hoitt J, Damle N, Sikand VJ. Prospective study of coinfection in patients with erythema migrans. Clin Infect Dis 2003; 36:1078-81.
8. Logigian EL, Steere AC. Clinical and electrophysiologic findings in chronic neuropathy of Lyme disease. Neurology 1992; 42:303-11.
9. Wormser GP, Dattwyler RJ, Shapiro ED, et al. The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 2006; 43:1089-134.
10. Craft JE, Grodzicki RL, Steere AC. The antibody response in Lyme disease: evaluation of diagnostic tests. J Infect Dis 1984; 149:789-95.
11. Peltomaa M, McHugh G, Steere AC. Persistence of the antibody response to the VlsE sixth invariant region (IR6) peptide of Borrelia burgdorferi after successful antibiotic treatment of Lyme disease. J Infect Dis 2003; 187:1178-86.
12. Dressler F, Whalen JA, Reinhardt BN, Steere AC. Western blotting in the serodiagnosis of Lyme disease. J Infect Dis 1993; 167:392-400.
13. Craven RB, Quan TJ, Bailey RE, et al. Improved serodiagnostic testing for Lyme disease: results of a multicenter serologic evaluation. Emerg Infect Dis 1996; 2:136-40.
14. Trevejo RT, Krause PJ, Schriefer ME, Dennis DT. Evaluation of a two-test serodiagnostic method for community assessment of Lyme disease in an endemic area. Am J Trop Med Hyg 2001; 65:563-6.
15. Nocton JJ, Dressler F, Rutledge BJ, Rys PN, Persing DH, Steere AC. Detection of Borrelia burgdorferi DNA by polymerase chain reaction in synovial fluid in Lyme arthritis. N Engl J Med 1994; 330:229-34.
16. Bradley JF, Johnson RC, Goodman JL. The persistence of spirochetal nucleic acids in active Lyme arthritis. Ann Intern Med 1994; 120:487-9.
17. Coyle PK, Goodman JL, Krupp LB, Logigian EL, Reik LJ. Lyme disease. In: Continuum: lifelong learning in neurology. Philadelphia: Lippincott Williams & Wilkins, 1999.
18. Nocton JJ, Bloom BJ, Rutledge BJ, et al. Detection of Borrelia burgdorferi DNA by polymerase chain reaction in cerebrospinal fluid in patients with Lyme neuroborreliosis. J Infect Dis 1996; 174:623-7.
19. Barthold SW, DeSouza MS, Janotka JL, Smith AL, Persing DH. Chronic Lyme borreliosis in the laboratory mouse. Am J Path 1993; 143:959-71.
20. Schaible UE, Gern L, Wallich R, Kramer MD, Prester M, Simon MM. Distinct patterns of protective antibodies are generated against Borrelia burgdorferi in mice experimentally inoculated with high and low doses of antigen. Immunol Lett 1993; 36:219-26.
21. Dattwyler RJ, Volkman DJ, Luft BJ, Halperin JJ, Thomas J, Golightly MG. Seronegative Lyme disease: dissociation of the specific T- and B-lymphocyte responses to Borrelia burgdorferi. N Engl J Med 1988; 319:1441-6.
22. Klempner MS, Hu LT, Evans J, et al. Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease. N Engl J Med 2001; 345:85-92.
23. Feder HM Jr, Johnson BJ, O'Connell S, Shapiro ED, Steere AC, Wormser GP. A critical appraisal of "chronic Lyme disease". N Engl J Med 2007; 357:1422-30.
24. Kannian P, McHugh G, Johnson BJ, Bacon RM, Glickstein LJ, Steere AC. Antibody responses to Borrelia burgdorferi in patients with antibiotic-refractory, antibiotic responsive, or non-antibiotic-treated Lyme arthritis. Arthritis Rheum 2007; 56:4216-25.
25. Rose CD, Fawcett PT, Gibney KM, Doughty RA. Residual serologic reactivity in children with resolved Lyme arthritis. J Rheumatol 1996; 23:367-9.
26. Philipp MT, Bowers LC, Fawcett PT, et al. Antibody response to IR6, a conserved immunodominant region of the VlsE lipoprotein, wanes rapidly after antibiotic treatment of Borrelia burgdorferi infection in experimental animals and in humans. J Infect Dis 2001; 184:870-8.
27. Kalish RA, McHugh G, Granquist J, Shea B, Ruthazer R, Steere AC. Persistence of immunoglobulin M or immunoglobulin G antibody responses to Borrelia burgdorferi 10-20 years after active Lyme disease. Clin Infect Dis 2001; 33:780-5.
28. Greer DM, Schaefer PW, Plotkin SR, Hasserjian RP, Steere AC. Case records of the Massachusetts General Hospital. Case 11-2007. A 59-year-old man with neck pain, weakness in the arms, and cranial-nerve palsies. N Engl J Med 2007; 356:1561-70.
29. Steere AC, Sikand VK, Schoen RT, Nowakowski J. Asymptomatic infection with Borrelia burgdorferi. Clin Infect Dis 2003; 37:528-32.
30. Mogilyansky E, Loa CC, Adelson ME, Mordechai E, Tilton RC. Comparison of Western immunoblotting and the C6 Lyme antibody test for laboratory detection of Lyme disease. Clin Diagn Lab Immunol 2004; 11:924-9.
31. Porwancher R. A reanalysis of IgM Western blot criteria for the diagnosis of early Lyme disease. J Infect Dis 1999; 179:1021-4.